A61P 37/00
Drugs for immunological or allergic disorders
A61P37/00 (Drugs for immunological or allergic disorders) appears on 50,507 US grants and 75,913 published applications in this corpus.
Search patents in A61P- Granted patents
- 50,507
- Published applications
- 75,913
- Assignees
- 15,549
- Inventors
- 98,618
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 14 | 0 |
| 1978 | 35 | 0 |
| 1979 | 40 | 0 |
| 1980 | 66 | 0 |
| 1981 | 56 | 0 |
| 1982 | 60 | 0 |
| 1983 | 71 | 0 |
| 1984 | 85 | 0 |
| 1985 | 78 | 0 |
| 1986 | 99 | 0 |
| 1987 | 132 | 0 |
| 1988 | 101 | 0 |
| 1989 | 167 | 0 |
| 1990 | 184 | 0 |
| 1991 | 191 | 0 |
| 1992 | 195 | 0 |
| 1993 | 186 | 0 |
| 1994 | 213 | 0 |
| 1995 | 257 | 0 |
| 1996 | 337 | 0 |
| 1997 | 475 | 0 |
| 1998 | 682 | 0 |
| 1999 | 901 | 0 |
| 2000 | 815 | 0 |
| 2001 | 999 | 266 |
| 2002 | 1054 | 1493 |
| 2003 | 1007 | 2408 |
| 2004 | 796 | 2865 |
| 2005 | 840 | 2766 |
| 2006 | 1160 | 2829 |
| 2007 | 1230 | 2952 |
| 2008 | 1317 | 3588 |
| 2009 | 1672 | 3976 |
| 2010 | 2152 | 4661 |
| 2011 | 2371 | 4649 |
| 2012 | 2661 | 4450 |
| 2013 | 2956 | 3505 |
| 2014 | 2936 | 3482 |
| 2015 | 2645 | 3304 |
| 2016 | 2455 | 3340 |
| 2017 | 2565 | 3184 |
| 2018 | 2290 | 2953 |
| 2019 | 2256 | 3115 |
| 2020 | 2096 | 2653 |
| 2021 | 1780 | 2578 |
| 2022 | 1449 | 2488 |
| 2023 | 1230 | 2449 |
| 2024 | 1236 | 2451 |
| 2025 | 1219 | 1983 |
| 2026 | 688 | 1525 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cannabidiol nanodrug formulations and methods for use of the same6 Oct 2026US 12,751,959 B2University of Miami
- Composition for prevention, amelioration, or treatment of hypersensitivity immune disease containing galactose6 Oct 2026US 12,751,961 B2Quorum Bio Co., Ltd.
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Composition for preventing or treating inflammatory bowel disease6 Oct 2026US 12,751,979 B2Ajou University Industry-Academic Cooperation Foundation
- Composition for inhibiting proliferation of tumor comprising Rubus coreanus extract as effective component6 Oct 2026US 12,751,986 B2Korea Institute of Oriental Medicine
- Methods of treating diseases and disorders associated with foxp3 expression8 Oct 2026US 2026/0306482 A1Northwestern University
- Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of bruton's tyrosine kinase8 Oct 2026US 2026/0306487 A1Genentech, Inc.
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Enhancer of number of tcr clones8 Oct 2026US 2026/0306562 A1Kabushiki Kaisha Yakult Honsha
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Drug releasing anastomosis devices and methods for treating anastomotic sites1,779US 7,108,701 B2Ethicon, Inc. · 2006
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003